Zealand Pharma Lands Novel Eli Lilly R&D Deal In Diabetes And Obesity
This article was originally published in The Pink Sheet Daily
Executive Summary
Zealand Pharma has landed another major partnership, this time with Lilly to help develop what the Danish biotech hopes will be a novel, best-in-class treatment for obesity and type 2 diabetes. The process will take years but could lead to other innovative drug deals with the U.S. drug maker.